Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 17 studies | 44% ± 19% | |
Mueller cell | 4 studies | 58% ± 19% | |
retinal bipolar neuron | 3 studies | 27% ± 7% | |
rod bipolar cell | 3 studies | 46% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 3275.85 | 2565 / 2642 | 96% | 41.99 | 677 / 705 |
liver | 97% | 764.34 | 219 / 226 | 69% | 9.37 | 280 / 406 |
skin | 63% | 212.37 | 1132 / 1809 | 80% | 22.63 | 377 / 472 |
esophagus | 83% | 411.88 | 1197 / 1445 | 33% | 1.45 | 60 / 183 |
eye | 0% | 0 | 0 / 0 | 98% | 37.24 | 78 / 80 |
prostate | 8% | 19.15 | 20 / 245 | 72% | 3.96 | 360 / 502 |
uterus | 25% | 91.51 | 43 / 170 | 53% | 3.16 | 243 / 459 |
bladder | 52% | 188.86 | 11 / 21 | 21% | 1.30 | 107 / 504 |
breast | 14% | 29.28 | 62 / 459 | 58% | 3.26 | 647 / 1118 |
kidney | 7% | 18.69 | 6 / 89 | 47% | 3.56 | 422 / 901 |
pancreas | 27% | 65.39 | 87 / 328 | 26% | 1.21 | 47 / 178 |
spleen | 51% | 150.15 | 124 / 241 | 0% | 0 | 0 / 0 |
ovary | 1% | 0.93 | 1 / 180 | 51% | 2.61 | 218 / 430 |
tonsil | 0% | 0 | 0 / 0 | 47% | 2.28 | 21 / 45 |
lung | 2% | 2.97 | 9 / 578 | 43% | 3.58 | 493 / 1155 |
stomach | 29% | 120.97 | 103 / 359 | 15% | 1.00 | 44 / 286 |
intestine | 12% | 27.18 | 113 / 966 | 21% | 0.93 | 113 / 527 |
blood vessel | 12% | 30.58 | 154 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 7% | 0.58 | 15 / 230 |
muscle | 6% | 16.94 | 48 / 803 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 6% | 0.30 | 36 / 605 |
adipose | 4% | 8.88 | 45 / 1204 | 0% | 0 | 0 / 0 |
heart | 0% | 0.25 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0042416 | Biological process | dopamine biosynthetic process |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0031987 | Biological process | locomotion involved in locomotory behavior |
GO_0045964 | Biological process | positive regulation of dopamine metabolic process |
GO_0016358 | Biological process | dendrite development |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030425 | Cellular component | dendrite |
GO_0009986 | Cellular component | cell surface |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0042277 | Molecular function | peptide binding |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0008528 | Molecular function | G protein-coupled peptide receptor activity |
GO_0042923 | Molecular function | neuropeptide binding |
GO_0008188 | Molecular function | neuropeptide receptor activity |
GO_0030544 | Molecular function | Hsp70 protein binding |
GO_0036505 | Molecular function | prosaposin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GPR37 |
Protein name | Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1) (ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor) (PAELR) |
Synonyms | |
Description | FUNCTION: G-protein-coupled receptor that plays a role in several physiological pathways such as resolution of inflammatory pain and oligodendrocyte differentiation (By similarity). Acts as a receptor for several ligands including prosaposin, osteocalcin or neuroprotectin D1. Ligand binding induces endocytosis, followed by an ERK phosphorylation cascade . Acts as a receptor for osteocalcin (OCN) to regulate oligodendrocyte differentiation and central nervous system myelination. Mechanistically, plays a negative role in oligodendrocyte differentiation and myelination during development via activation of the ERK1/2 signaling pathway. Therefore, regulates the stability of myelin or resistance of myelin itself to demyelination. Upon activation by neuroprotectin D1 (NPD1), promotes the activation of phagocytosis in macrophages as well as the shift in cytokine release toward an anti-inflammatory profile, and thus helps to reverse inflammatory pain. In addition, the increased macrophage phagocytosis mediates protection against sepsis upon pathogen infection. Additionally, extracellular vesicles derived from efferocyte express prosaposin, which binds to macrophage GPR37 to increase expression of the efferocytosis receptor TIM4 via an ERK-AP1-dependent signaling axis, leading to increased macrophage efferocytosis efficiency and accelerated resolution of inflammation (By similarity). May also act as a maturation factor of LRP6, protecting LRP6 from the endoplasmic reticulum (ER)-associated protein degradation (ERAD) and thereby promoting the Wnt/beta-catenin signaling pathway . . |
Accessions | O15354 ENST00000303921.3 |